AFP and hepatocellular carcinoma: Our findings demonstrate that hypoxia-responsive and enhancer region-modified AFP promoter can efficiently drive the replication of oncolytic Ad in a highly HCC-specific manner and enable the virus to overcome the hypoxic tumor microenvironment, ultimately resulting in potent inhibition of tumor growth with minimal hepatotoxicity.